Learn More
Enzo Life Sciences BML-282 (5mg)

Supplier: Enzo Life Sciences BMLEI4000005

Novel inhibitor of ubiquitin C-terminal hydrolase L1 (IC50 = 0.81 µM). It displays 21-fold greater selectivity over UCH-L3 (IC50 = 17 µM). Alternative name: N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (5mg/ml with warming) or dimethyl formamide (10mg/ml with warming). Long Term Storage: -20°C.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.